The process followed in the development of the paediatric food-based dietary guidelines for South Africa

Lesley T Bourne1, Debbie Marais, Penny Love

  • 1Environment & Health Unit, Medical Research Council of South Africa, Cape Town, South Africa. lbourne@mrc.ac.za

Maternal & Child Nutrition
|September 11, 2007
PubMed

Insights

South Africa developed preliminary food-based dietary guidelines for children up to 7 years old. These guidelines, tailored for specific age groups, aim to improve pediatric nutrition using local evidence.

Area of Science:

  • Nutrition Science
  • Public Health Policy
  • Pediatrics

Background:

  • International recommendations in 1996 called for country-specific food-based dietary guidelines (FBDGs).
  • South Africa initiated FBDG development in 1997 for the general population and later for priority groups.
  • This led to the formation of a Paediatric FBDG Working Group in 2000 to address children's nutritional needs.

Purpose of the Study:

  • To develop specific Paediatric Food-Based Dietary Guidelines (PFBDGs) for South African children.
  • To establish age-appropriate guidelines for children up to 7 years, covering three subcategories: 0-6 months, 6-12 months, and 12-84 months.
  • To ensure guidelines are based on scientific evidence and local context.

Main Methods:

  • Literature review and stakeholder consultations were conducted.
  • Preliminary PFBDGs were developed for three distinct age subcategories.
  • Qualitative methodologies were employed for comprehensibility and consumer testing of the proposed guidelines.

Main Results:

  • Preliminary PFBDGs were approved for consumer testing in May 2003.
  • The guidelines were deemed appropriate for each age group based on scientific and local evidence.
  • Initial evaluation utilized qualitative methodologies, with further testing needed for diverse populations.

Conclusions:

  • Preliminary paediatric food-based dietary guidelines have been developed for South African children up to 7 years.
  • These guidelines represent a significant step towards improving child nutrition in the country.
  • Further research and testing are essential to refine and validate these guidelines for all diverse groups.

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Sources of Food Contamination01:29

Sources of Food Contamination

Contamination of food by microbial agents and natural toxins poses significant risks to public health. These hazards can be introduced at various points across the food supply chain, ranging from environmental sources to processing and storage stages. Understanding these contamination pathways is critical for developing strategies to ensure food safety.Seafood is particularly vulnerable to contamination through both environmental exposure and microbial colonization. Toxins from harmful algal...